U.S. flag An official website of the United States government
  1. Home
  2. Science & Research
  3. About Science & Research at FDA
  4. FDA Grand Rounds
  1. About Science & Research at FDA
FDA Grand Rounds

The FDA Grand Rounds is an educational presentation that is webcast monthly to highlight cutting-edge research underway across the Agency and its impact on protecting and advancing public health. Each session features an FDA scientist presenting on a key public health challenge and how FDA is applying science to its regulatory activities. The 45-minute educational presentation is followed by questions from the audience. You can also view the presentation under Past Grand Rounds following the live webcast. #FDAGrandRounds.

Upcoming Event

Identification of Persistent Organic Pollutants in Foods: Method Development and Automation

Thursday, April 13, 2023
12:00 p.m. - 1:00 p.m. EST

About the Presentation

The gold standard for the determination of legacy Persistent Organic Pollutants (POPs) which includes polychlorinated dibenzo-p-dioxins (PCDDs), polychlorinated dibenzofurans (PCDFs), polychlorinated biphenyls (PCBs), and polybrominated diphenyl ethers (PBDEs) had not significantly evolved for over 40 years.  In this presentation, the new instrumentation, extraction procedures, as well as novel data processing and evaluations used in an accredited laboratory will be discussed.  Similar streamlined methodologies and software processes are now being evaluated for per- and polyfluorinated alkyl substances (PFAS) determinations in an accredited laboratory.

Past Grand Rounds









Resources For You

Sub-Topic Paragraphs

Latest From the Commissioner

FDA Outlines Steps to Strengthen Tobacco Program

Feb 24

La FDA delinea pasos para fortalecer el Programa Antitabaco

Feb 24

FDA Advances Additional Activities to Prevent Drug Overdoses and Reduce Death

Feb 16

The Federal Response to COVID-19 - 02/08/2023

Feb 08

FDA Proposes Redesign of Human Foods Program to Enhance Coordinated Prevention and Response Activities

Jan 31

FDA Concludes that Existing Regulatory Frameworks for Foods and Supplements are Not Appropriate for Cannabidiol, Will Work with Congress on a New Way Forward

Jan 26

La FDA concluye que los marcos regulatorios existentes para alimentos y suplementos no son apropiados para el cannabidiol, trabajará con el Congreso en una nueva forma de proceder

Jan 26

Remarks by Commissioner Robert M. Califf, M.D. at the FDA-U.S. Patent and Trademark Office Public Workshop - 01/19/2023

Jan 19

Subscribe to FDA Grand Rounds email updates

The latest information on the FDA Grand Rounds

Back to Top